Cognitive effects of oxybutynin chloride topical gel in older healthy subjects: a 1-week, randomized, double-blind, placebo- and active-controlled study.

Clinical drug investigation 20121001

Early administration of oxybutynin improves bladder function and clinical outcomes in newborns with posterior urethral valves.

The Journal of urology 20121001

[Medication in the elderly : cognitive impairment by drugs].

Der Internist 20121001

Intravesical treatment of painful bladder syndrome: a systematic review and meta-analysis.

International urogynecology journal 20120901

Characterization of bladder selectivity of antimuscarinic agents on the basis of in vivo drug-receptor binding.

International neurourology journal 20120901

An evaluation of patient and physician satisfaction with controlled-release oxybutynin 15 mg as a one-step daily dose in elderly and non-elderly patients with overactive bladder: results of the STOP study.

Current medical research and opinion 20120801

A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs.

Drugs & aging 20120801

Bryophyllum pinnatum inhibits detrusor contractility in porcine bladder strips--a pharmacological study towards a new treatment option of overactive bladder.

Phytomedicine : international journal of phytotherapy and phytopharmacology 20120715

Cost-effectiveness analysis of newer anticholinergic drugs for urinary incontinence vs oxybutynin and no treatment using data on persistence from the Swedish prescribed drug registry.

BJU international 20120701

Comparative adherence to oxybutynin or tolterodine among older patients.

European journal of clinical pharmacology 20120701

Simultaneous absolute protein quantification of carboxylesterases 1 and 2 in human liver tissue fractions using liquid chromatography-tandem mass spectrometry.

Drug metabolism and disposition: the biological fate of chemicals 20120701

The effects of oxybutynin on urinary symptoms in children with Williams-Beuren syndrome.

The Journal of urology 20120701

[Hyperthermia in spina bifida patients treated with oxybutynin].

Der Urologe. Ausg. A 20120701

Patient-reported goal achievement after antimuscarinic treatment in patients with overactive bladder symptoms.

International journal of clinical practice 20120701

Benefits and harms of pharmacologic treatment for urinary incontinence in women: a systematic review.

Annals of internal medicine 20120619

A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis.

Journal of vascular surgery 20120601

Practical consensus guidelines for the management of enuresis.

European journal of pediatrics 20120601

Oxybutynin gel for the treatment of overactive bladder.

Expert opinion on pharmacotherapy 20120601

Lower urinary tract symptoms revisited.

International journal of clinical practice 20120601

Conclusive identification of the oxybutynin-hydrolyzing enzyme in human liver.

Drug metabolism and disposition: the biological fate of chemicals 20120501

Effective and clinically meaningful non-hormonal hot flash therapies.

Maturitas 20120501

Efficacy and safety of propiverine in children with overactive bladder.

Korean journal of urology 20120401

Radiofrequency sacral rhizotomy for the management of intolerable neurogenic bladder in spinal cord injured patients.

Annals of rehabilitation medicine 20120401

Systemic therapy for primary hyperhidrosis: a retrospective study of 59 patients treated with glycopyrrolate or clonidine.

Journal of the American Academy of Dermatology 20120301

1,4-dioxane, a suitable scaffold for the development of novel M₃ muscarinic receptor antagonists.

Journal of medicinal chemistry 20120223

Efficacy and safety of oxybutynin chloride topical gel for women with overactive bladder syndrome.

American journal of obstetrics and gynecology 20120201

Anticholinergics for overactive bladder therapy: central nervous system effects.

CNS neuroscience & therapeutics 20120201

Prescription pattern of oxybutynin ER in patients with overactive bladder in real life practice: a multicentre, open-label, prospective observational study.

International journal of clinical practice 20120201

Which anticholinergic drug for overactive bladder symptoms in adults.

The Cochrane database of systematic reviews 20120118

Comparative adherence to oxybutynin or tolterodine among older patients.

European journal of clinical pharmacology 20120101

A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence.

Patient preference and adherence 20120101

Cortical blindness in a child with acute glomerulonephritis.

Indian journal of nephrology 20120101

Neurogenic bladder.

Advances in urology 20120101

Treating acute cystitis with biodegradable micelle-encapsulated quercetin.

International journal of nanomedicine 20120101

Got to go! Resolving day and night time enuresis in younger children.

The journal of family health care 20120101

Mining online social network data for biomedical research: a comparison of clinicians' and patients' perceptions about amyotrophic lateral sclerosis treatments.

Journal of medical Internet research 20120101

[Catheter-related bladder discomfort in post-anaesthesia care unit].

Annales francaises d'anesthesie et de reanimation 20120101

An overview on mixed action drugs for the treatment of overactive bladder and detrusor overactivity.

Urologia internationalis 20120101

Urinary Urgency Medications May Compromise Discrete rather than Global Cognitive Skills.

Dementia and geriatric cognitive disorders extra 20120101

Combination of baclofen and antimuscarinics to reduce voiding difficulty in treating women with overactive bladders.

Clinical and experimental obstetrics & gynecology 20120101

Oxybutynin reduces sweating in depressed patients treated with sertraline: a double-blind, placebo-controlled, clinical study.

Neuropsychiatric disease and treatment 20120101

An investigation of the safety and pharmacokinetics of the novel TRPV1 antagonist XEN-D0501 in healthy subjects.

British journal of clinical pharmacology 20111201

An alternative to treat palmar hyperhidrosis: use of oxybutynin.

Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20111201

Urothelial/lamina propria spontaneous activity and the role of M3 muscarinic receptors in mediating rate responses to stretch and carbachol.

Urology 20111201

Behavioral versus drug treatment for overactive bladder in men: the Male Overactive Bladder Treatment in Veterans (MOTIVE) Trial.

Journal of the American Geriatrics Society 20111201

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

PLoS computational biology 20111201

Efficacy of oral extended-release oxybutynin in cognitively impaired older nursing home residents with urge urinary incontinence: a randomized placebo-controlled trial.

Journal of the American Medical Directors Association 20111101

The use of oxybutynin for treating axillary hyperhidrosis.

Annals of vascular surgery 20111101

Antimuscarinic drugs: review of the cognitive impact when used to treat overactive bladder in elderly patients.

Current urology reports 20111001

Alternatives to potentially inappropriate medications for use in e-prescribing software: triggers and treatment algorithms.

BMJ quality & safety 20111001

Risk of serious falls associated with oxybutynin and tolterodine: a population based study.

The Journal of urology 20111001

[Retrospective studies and therapeutic research].

Annales de dermatologie et de venereologie 20111001

[Therapeutic value of moderate-dose oxybutynin in extensive hyperhidrosis].

Annales de dermatologie et de venereologie 20111001

Chronic use of oxybutynin and spinal anesthesia: a case of postoperative urinary retention and hematuria.

Middle East journal of anaesthesiology 20111001

National-wide data on the treatment of BPH in Korea.

Prostate cancer and prostatic diseases 20110901

Randomized trial of estradiol vaginal ring versus oral oxybutynin for the treatment of overactive bladder.

Menopause (New York, N.Y.) 20110901

Effect of oxybutynin and imidafenacin on central muscarinic receptor occupancy and cognitive function: a monkey PET study with [(11)C](+)3-MPB.

NeuroImage 20110901

Characterization of muscarinic receptors in the human bladder mucosa: direct quantification of subtypes using 4-DAMP mustard.

Urology 20110901

Immediate-release oxybutynin for the treatment of clozapine-induced sialorrhea.

The Annals of pharmacotherapy 20110901

More treatment options for overactive bladder in postmenopausal women.

Menopause (New York, N.Y.) 20110901

Optimal sedative dose of propofol to start MRI in children with cerebral palsy.

Korean journal of anesthesiology 20110901

α1-Adrenoceptors and muscarinic receptors in voiding function - binding characteristics of therapeutic agents in relation to the pharmacokinetics.

British journal of clinical pharmacology 20110801

Nocturnal enuresis-theoretic background and practical guidelines.

Pediatric nephrology (Berlin, Germany) 20110801

A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder.

British journal of clinical pharmacology 20110801

Voiding dysfunction: another etiology of vulvovaginitis in young girls.

Journal of pediatric and adolescent gynecology 20110801

Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2.

Journal of medicinal chemistry 20110714

Validity and reliability of patient selected goals as an outcome measure in overactive bladder.

International urogynecology journal 20110701

Comparative analysis of the effects of antimuscarinic agents on bladder functions in both nonhuman primates and rodents.

The Journal of pharmacology and experimental therapeutics 20110701

Urinary incontinence, hyperthermia, and sudden death.

Journal of forensic sciences 20110701

Systematic review and meta-analysis: do clinical trials testing antimuscarinic agents for overactive bladder adequately measure central nervous system adverse events?

Journal of the American Geriatrics Society 20110701

Use of an inflatable silicone balloon improves the success rate of bladder autoaugmentation at long-term followup.

The Journal of urology 20110601

Validity and reliability of the patient's perception of intensity of urgency scale in overactive bladder.

BJU international 20110501

Oxybutynin for treatment of nocturnal enuresis in children.

Canadian family physician Medecin de famille canadien 20110501

Electrical stimulation of the urethra evokes bladder contractions and emptying in spinal cord injury men: case studies.

The journal of spinal cord medicine 20110501

Treatment choice, duration, and cost in patients with interstitial cystitis and painful bladder syndrome.

International urogynecology journal 20110401

Antimuscarinics for treatment of storage lower urinary tract symptoms in men: a systematic review.

International journal of clinical practice 20110401

Efficacy and safety of low-dose propiverine in patients with lower urinary tract symptoms/benign prostatic hyperplasia with storage symptoms: a prospective, randomized, single-blinded and multicenter clinical trial.

Korean journal of urology 20110401

Determination of oxybutynin in pharmaceuticals via reaction with mixed acids anhydrides: application to content uniformity testing.

Journal of fluorescence 20110301

Anticholinergics do not improve cure rate of alarm treatment of monosymptomatic nocturnal enuresis.

Urology 20110301

Hollow fiber-based liquid-phase microextraction (HF-LPME) of isradipine and its main metabolite followed by chiral HPLC analysis: application to an in vitro biotransformation study.

Analytical and bioanalytical chemistry 20110301

Effects of anticholinergic drugs on verbal episodic memory function in the elderly: a retrospective, cross-sectional study.

Drugs & aging 20110301

Oxybutynin for antidepressant-induced hyperhidrosis.

The American journal of psychiatry 20110301

Editorial comment. Anticholinergics do not improve cure rate of alarm treatment of monosymptomatic nocturnal enuresis.

Urology 20110301

Evaluation of brain anticholinergic activities of urinary spasmolytic drugs using a high-throughput radio receptor bioassay.

Journal of the American Geriatrics Society 20110301

Selective binding of bladder muscarinic receptors in relation to the pharmacokinetics of a novel antimuscarinic agent, imidafenacin, to treat overactive bladder.

The Journal of pharmacology and experimental therapeutics 20110201

Tolerability of solifenacin and oxybutynin immediate release in older (> 65 years) and younger (≤ 65 years) patients with overactive bladder: sub-analysis from a Canadian, randomized, double-blind study.

Current medical research and opinion 20110201

Inappropriate prescribing in older residents of Australian care homes.

Journal of clinical pharmacy and therapeutics 20110201

Oxybutynin and trospium are substrates of the human organic cation transporters.

Naunyn-Schmiedeberg's archives of pharmacology 20110201

Predictors of catheter-related bladder discomfort in the post-anaesthesia care unit.

Annales francaises d'anesthesie et de reanimation 20110201

Traditional suburethral sling operations for urinary incontinence in women.

The Cochrane database of systematic reviews 20110119

Overactive bladder drugs and constipation: a meta-analysis of randomized, placebo-controlled trials.

Digestive diseases and sciences 20110101

Patient-selected goals in overactive bladder: a placebo controlled randomized double-blind trial of transdermal oxybutynin for the treatment of urgency and urge incontinence.

BJU international 20110101

The efficacy of enuresis alarm treatment in pharmacotherapy-resistant nocturnal enuresis.

Urology 20110101

[Comparisons of efficacy and safety of tolterodine and oxybutynin in children with idiopathic overactive bladder].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 20110101

Specific pharmacokinetic aspects of the urinary tract.

Handbook of experimental pharmacology 20110101

Adverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approach.

PloS one 20110101

Paliperidone extended-release: does it have a place in antipsychotic therapy?

Drug design, development and therapy 20110101

Nocturnal enuresis.

BMJ clinical evidence 20110101

Urodynamic parameters development and complications of clean intermittent self-catheterization in Chinese schoolchildren with neurogenic underactive bladder.

Urologia internationalis 20110101

Study protocol: ICONS: identifying continence options after stroke: a randomised trial.

Trials 20110101

An overview of the clinical use of antimuscarinics in the treatment of overactive bladder.

Advances in urology 20110101

Solifenacin in multiple sclerosis patients with overactive bladder: a prospective study.

Advances in urology 20110101

Pharmacokinetics of oxybutynin chloride topical gel: effects of application site, baths, sunscreen and person-to-person transference.

Clinical drug investigation 20110101

The use of oxybutynin for treating facial hyperhidrosis.

Anais brasileiros de dermatologia 20110101

The efficacy and safety of propiverine hydrochloride in patients with overactive bladder symptoms who poorly responded to previous anticholinergic agents.

Advances in urology 20110101

Oxybutynin dependence: a case presentation.

Turk psikiyatri dergisi = Turkish journal of psychiatry 20110101

Cutaneous reactions to transdermal therapeutic systems.

Dermatitis : contact, atopic, occupational, drug 20110101

Overactive bladder: the importance of tailoring treatment to the individual patient.

Journal of multidisciplinary healthcare 20110101

Bladder, bowel, and sexual dysfunction in Parkinson's disease.

Parkinson's disease 20110101

Symptomatic therapy and rehabilitation in primary progressive multiple sclerosis.

Neurology research international 20110101

Use of CNS medications and cognitive decline in the aged: a longitudinal population-based study.

BMC geriatrics 20110101

Comparative Evaluation of the Safety and Efficacy of Long-Term Use of Imidafenacin and Solifenacin in Patients with Overactive Bladder: A Prospective, Open, Randomized, Parallel-Group Trial (the LIST Study).

Advances in urology 20110101

Spinal versus General Anaesthesia in Postoperative Pain Management during Transurethral Procedures.

ISRN urology 20110101

Tolerance of bladder antispasmodics in children with urinary incontinence: An observational study from North India.

Indian journal of pharmacology 20110101

Fast disintegrating tablets: Opportunity in drug delivery system.

Journal of advanced pharmaceutical technology & research 20110101

Idiopathic urgency urinary incontinence.

The New England journal of medicine 20101230

Intravesical oxybutynin protects the vesical wall against functional and smooth muscle changes in rabbits with detrusor overactivity.

International urogynecology journal 20101201

Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.

Toxicological sciences : an official journal of the Society of Toxicology 20101201

Correlation of male overactive bladder with intravesical prostatic protrusion.

Korean journal of urology 20101201

Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method.

Healthcare informatics research 20101201

Catalytic asymmetric dihydroxylation of enamides and application to the total synthesis of (+)-tanikolide.

Angewandte Chemie (International ed. in English) 20101108

Treatment options for parasomnias.

Neurologic clinics 20101101

Correlation between Nocturia and Sleep: A Questionnaire Based Analysis.

Korean journal of urology 20101101

Loss of muscarinic and purinergic receptors in urinary bladder of rats with hydrochloric acid-induced cystitis.

Urology 20101001

Prospective open label study of solifenacin for overactive bladder in children.

The Journal of urology 20101001

New insights into molecular targets for urinary incontinence.

Indian journal of pharmacology 20101001

Discovering drug-drug interactions: a text-mining and reasoning approach based on properties of drug metabolism.

Bioinformatics (Oxford, England) 20100915

Sample size/power calculations for population pharmacodynamic experiments involving repeated-count measurements.

Journal of biopharmaceutical statistics 20100901

Correlation between pharmacologically-induced changes in cystometric parameters and spinal c-Fos expression in rats.

Autonomic neuroscience : basic & clinical 20100825

Efficacy, tolerability and safety of propiverine hydrochloride in comparison to oxybutynin in children with urge incontinence due to overactive bladder: Results of a multicentre observational cohort study.

BJU international 20100801

The cost-effectiveness of solifenacin vs fesoterodine, oxybutynin immediate-release, propiverine, tolterodine extended-release and tolterodine immediate-release in the treatment of patients with overactive bladder in the UK National Health Service.

BJU international 20100801

Oxybutynin and propiverine suppress adenosine triphosphate-induced bladder overactivity other than through antimuscarinic mechanisms.

Urology 20100801

Combined behavioral and individualized drug therapy versus individualized drug therapy alone for urge urinary incontinence in women.

The Journal of urology 20100801

Noninvasive evaluation of brain muscarinic receptor occupancy of oxybutynin, darifenacin and imidafenacin in rats by positron emission tomography.

Life sciences 20100731

AE9C90CB: a novel, bladder-selective muscarinic receptor antagonist for the treatment of overactive bladder.

British journal of pharmacology 20100701

Two unusual pediatric cases of dilutional hyponatremia.

Pediatric emergency care 20100701

New strategies for medical management of overactive bladder in children.

Current opinion in urology 20100701

Therapy: Solifenacin causes less dry mouth than oxybutynin in OAB.

Nature reviews. Urology 20100601

Oxybutynin topical and transdermal formulations: an update.

Drugs of today (Barcelona, Spain : 1998) 20100601

Electrical stimulation of the urethra evokes bladder contractions in a woman with spinal cord injury.

The journal of spinal cord medicine 20100601

Tolerability of 5 mg solifenacin once daily versus 5 mg oxybutynin immediate release 3 times daily: results of the VECTOR trial.

The Journal of urology 20100501

Treatment of generalized hyperhidrosis with oxybutynin in post-menopausal patients.

Acta dermato-venereologica 20100501

In women with urinary incontinence how necessary is cystometry?

JPMA. The Journal of the Pakistan Medical Association 20100501

Quantitative determination of oxybutynin hydrochloride by spectrophotometry, chemometry and HPTLC in presence of its degradation product and additives in different pharmaceutical dosage forms.

Talanta 20100315

The effect of intravesical oxybutynin on the ice water test and on electrical perception thresholds in patients with neurogenic detrusor overactivity.

Neurourology and urodynamics 20100301

Overactive bladder medication adherence when medication is free to patients.

The Journal of urology 20100301

Topical oxybutynin (Gelnique) for overactive bladder.

The Medical letter on drugs and therapeutics 20100208

Triple therapy in refractory detrusor overactivity: a preliminary study.

World journal of urology 20100201

Use of aripiprazole in clozapine induced enuresis: report of two cases.

Journal of Korean medical science 20100201

Pediatrics: combining antimuscarinics shows promise for overactive bladder.

Nature reviews. Urology 20100201

Management of hot flashes in women with breast cancer.

Current oncology (Toronto, Ont.) 20100201

Medication nonadherence secondary to drug-induced memory loss.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20100201

Oxybutynin permeation in skin: the influence of drug and solvent activity.

International journal of pharmaceutics 20100115

Editorial comment on: Cizolirtine citrate is safe and effective to treat urinary incontinence secondary to overactive bladder: a phase 2 proof-of-concept study.

European urology 20100101

Cizolirtine citrate is safe and effective for treating urinary incontinence secondary to overactive bladder: a phase 2 proof-of-concept study.

European urology 20100101

Editorial comment on: Cizolirtine citrate is safe and effective for treating urinary incontinence secondary to overactive bladder: a phase 2 proof-of-concept study.

European urology 20100101

Antimuscarinics in men with lower urinary tract symptoms suggestive of bladder outlet obstruction due to benign prostatic hyperplasia.

Current opinion in urology 20100101

The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: bladder selectivity based on in vivo drug-receptor binding characteristics of antimuscarinic agents for treatment of overactive bladder.

Journal of pharmacological sciences 20100101

Efficacy of combined oral-intravesical oxybutynin hydrochloride treatment for patients with overactive detrusors and indwelling urethral catheters.

Rehabilitation nursing : the official journal of the Association of Rehabilitation Nurses 20100101

Update on the pharmacologic management of overactive bladder: the present and the future.

Urologic nursing 20100101

Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tools, and possible solutions.

Clinical interventions in aging 20100101

Application of oxybutynin selective sensors for monitoring the dissolution profile and assay of pharmaceutical dosage forms.

Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20100101

Urodynamic Effects of Propiverine on Detrusor Overactivity and Abdominal Straining during Voiding in Awake Rats with Intravesical Prostaglandin E(2) Instillation.

Korean journal of urology 20100101

A comparative review of oxybutynin chloride formulations: pharmacokinetics and therapeutic efficacy in overactive bladder.

Reviews in urology 20100101

Chem2Bio2RDF: a semantic framework for linking and data mining chemogenomic and systems chemical biology data.

BMC bioinformatics 20100101

Bioadhesive controlled metronidazole release matrix based on chitosan and xanthan gum.

Marine drugs 20100101

Fatal Septicaemia Following Suprapubic Cystostomy in a Paraplegic Patient: Never Do a Cystostomy without Prior Urine Culture and Appropriate Antibiogram!

Case reports in medicine 20100101

A case of oxybutynin dependency.

General hospital psychiatry 20100101

Comparison of risk of neurovascular and cardiovascular side effects between tiotropium and other anticholinergic agents.

Quality in primary care 20100101

Canadian cost-effectiveness analysis of solifenacin compared to oxybutynin immediate-release in patients with overactive bladder.

Journal of medical economics 20100101

Dose escalation improves therapeutic outcome: post hoc analysis of data from a 12-week, multicentre, double-blind, parallel-group trial of trospium chloride in patients with urinary urge incontinence.

BMC urology 20100101

Tiotropium bromide inhibits TGF-β-induced MMP production from lung fibroblasts by interfering with Smad and MAPK pathways in vitro.

International journal of chronic obstructive pulmonary disease 20100101

Do anticholinergics affect reaction time? A possible impact on the course of rehabilitation.

NeuroRehabilitation 20100101

Hemorrhagic cystitis: A challenge to the urologist.

Indian journal of urology : IJU : journal of the Urological Society of India 20100101

Managing the urinary tract in spinal cord injury.

Indian journal of urology : IJU : journal of the Urological Society of India 20100101

Medical management of overactive bladder.

Indian journal of urology : IJU : journal of the Urological Society of India 20100101

[Optimization of enuresis therapy in children using transcranial magnetotherapy].

Urologiia (Moscow, Russia : 1999) 20100101

The trainees' perspective on developing an end-of-grant knowledge translation plan.

Implementation science : IS 20100101

Recent advances in management of bladder overactivity.

F1000 medicine reports 20100101

Gelnique (oxybutynin chloride) 10% gel for overactive bladder.

Urologic nursing 20100101

Sacral neuromodulation: Therapy evolution.

Indian journal of urology : IJU : journal of the Urological Society of India 20100101

New approaches in the management of multiple sclerosis.

Drug design, development and therapy 20100101

[Intravesical electrostimulation and magnetophoresis in overactive bladder in females: efficacy of Amus-01-Intramag device with Intrastim attachment].

Urologiia (Moscow, Russia : 1999) 20100101

Etiopathogenesis and management of bladder dysfunction in patients with posterior urethral valves.

Indian journal of urology : IJU : journal of the Urological Society of India 20100101

Bladder dysfunction in diabetes mellitus.

Frontiers in pharmacology 20100101

Cyclodextrin-MEEKC for the analysis of oxybutynin and its impurities.

Talanta 20091215

Basic mechanisms of urgency: roles and benefits of pharmacotherapy.

World journal of urology 20091201

Intravesical oxybutynin in the pediatric neurogenic bladder.

Nature reviews. Urology 20091201

Oxybutynin chloride topical gel: a new formulation of an established antimuscarinic therapy for overactive bladder.

Expert opinion on pharmacotherapy 20091201

Primary hyperhidrosis controlled with oxybutynin after unsuccessful surgical treatment.

Clinical and experimental dermatology 20091201

Treatment of dysautonomia associated with Parkinson's disease.

Parkinsonism & related disorders 20091201

Exploratory pilot study assessing the risk of cognitive impairment or sedation in the elderly following single doses of solifenacin 10 mg.

Expert opinion on drug safety 20091101

Trospium chloride and oxybutynin hydrochloride in a german study of adults with urinary urge incontinence: results of a 12-week, multicenter, randomized, double-blind, parallel-group, flexible-dose noninferiority trial.

Clinical therapeutics 20091101

Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia.

The Cochrane database of systematic reviews 20091007

Listening to the patient: a flexible approach to the use of antimuscarinic agents in overactive bladder syndrome.

BJU international 20091001

Comparison between oxybutynin, functional electrical stimulation and pelvic floor training for treatment of detrusor overactivity in women: a review.

Current opinion in obstetrics & gynecology 20091001

Efficacy and safety of oxybutynin transdermal system in spinal cord injury patients with neurogenic detrusor overactivity and incontinence: an open-label, dose-titration study.

Urology 20091001

Efficacy and safety of transdermal and oral oxybutynin in children with neurogenic detrusor overactivity.

The Journal of urology 20091001

Editorial comment.

The Journal of urology 20091001

Editorial comment.

The Journal of urology 20091001

Editorial comment.

The Journal of urology 20091001

Double anticholinergic therapy for refractory overactive bladder.

The Journal of urology 20091001

Effect of human chorionic gonadotrophin on in vitro contractions of stimulated detrusor muscle strips of female rats.

The journal of obstetrics and gynaecology research 20091001

[Effect of sublingual oxybutynin in postoperative pain after radical retropubic prostatectomy].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20090901

The evolution of transdermal therapy for overactive bladder.

Current urology reports 20090901

Spectrum of central anticholinergic adverse effects associated with oxybutynin: comparison of pediatric and adult cases.

The Journal of pediatrics 20090901

Comparison of muscarinic receptor selectivity of solifenacin and oxybutynin in the bladder and submandibular gland of muscarinic receptor knockout mice.

European journal of pharmacology 20090801

Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence.

International journal of clinical practice 20090801

Tolterodine extended release is well tolerated in older subjects.

International journal of clinical practice 20090801

Clinicians' views on the NICE guideline on the management of female urinary incontinence.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20090801

Treatment of overactive bladder in women.

Evidence report/technology assessment 20090801

Propiverinium picrate.

Acta crystallographica. Section E, Structure reports online 20090801

The effect of drug concentration on solvent activity in silicone membranes.

International journal of pharmaceutics 20090730

Urgency-free time interval as primary endpoint for evaluating the outcome of a randomized OAB treatment.

International urogynecology journal and pelvic floor dysfunction 20090701

Urinary incontinence: oxybutynin topical gel for overactive bladder.

Nature reviews. Urology 20090701

Estimating skin permeability from physicochemical characteristics of drugs: a comparison between conventional models and an in vivo-based approach.

International journal of pharmaceutics 20090622

Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study.

The Journal of urology 20090401

Comparison of the effect of anti-muscarinic agents on bladder activity, urinary ATP level, and autonomic nervous system in rats.

Biomedical research (Tokyo, Japan) 20090401

Propiverine vs oxybutynin for treating neurogenic detrusor overactivity in children and adolescents: results of a multicentre observational cohort study.

BJU international 20090301

Restoring continence in frail older people living in the community: what factors influence successful treatment outcomes?

Age and ageing 20090301

Pharmacological properties of TD-6301, a novel bladder selective muscarinic receptor antagonist.

European journal of pharmacology 20090301

Severe anticholinergic drug-induced delirium in a young adult after renal transplantation.

Transplant international : official journal of the European Society for Organ Transplantation 20090201

Protective action of intravesical oxybutynin on bladder ultrastructure in rabbits with detrusor overactivity.

International urogynecology journal and pelvic floor dysfunction 20090201

[Multinational clinical trial in Japan and Korea on detrusitol].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20090201

Trospium chloride treatment of overactive bladder.

The Annals of pharmacotherapy 20090201

[In vitro effects of a novel class of nitric oxide donating compounds on isolated human urinary bladder].

Georgian medical news 20090201

Anticholinergics for urinary symptoms in multiple sclerosis.

The Cochrane database of systematic reviews 20090121

Effect of long-term oxybutynin administration on c-Fos expression in spinal neurons: inhibition of antimuscarinics on bladder afferents in conscious rats.

Urology 20090101

The role of melanin-concentrating hormone-1 receptors in the voiding reflex in rats.

The Journal of pharmacology and experimental therapeutics 20090101

Muscarinic receptor antagonists for overactive bladder treatment: does one fit all?

Current opinion in urology 20090101

Transdermal oxybutynin.

Drugs 20090101

Solifenacin for overactive bladder in women unsuccessfully treated with immediate release oxybutynin: a pilot study.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20090101

Ratiometric Ca+2 measurement in human recombinant muscarinic receptor subtypes using the Flexstation scanning fluorometer.

Journal of receptor and signal transduction research 20090101

Surgical treatments for men with benign prostatic enlargement: cost effectiveness study.

BMJ (Clinical research ed.) 20090101

The evolution of transdermal/topical overactive bladder therapy and its benefits over oral therapy.

Reviews in urology 20090101

Impact of transdermal oxybutynin on work productivity in patients with overactive bladder: results from the MATRIX study.

PharmacoEconomics 20090101

The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly.

Clinical interventions in aging 20090101

The cognitive impact of anticholinergics: a clinical review.

Clinical interventions in aging 20090101

Clinical pharmacokinetics and pharmacodynamics of solifenacin.

Clinical pharmacokinetics 20090101

The evolution of transdermal/ topical overactive bladder therapy and its benefits over oral therapy.

Reviews in obstetrics & gynecology 20090101

Protocol for the value of urodynamics prior to stress incontinence surgery (VUSIS) study: a multicenter randomized controlled trial to assess the cost effectiveness of urodynamics in women with symptoms of stress urinary incontinence in whom surgical treatment is considered.

BMC women's health 20090101

A meta-analysis of the placebo response in antimuscarinic drug trials for overactive bladder.

BMC medical research methodology 20090101

Fatalities associated with clozapine-related constipation and bowel obstruction: a literature review and two case reports.

Psychosomatics 20090101

The prevention and treatment of cognitive decline and dementia: An overview of recent research on experimental treatments.

Indian journal of psychiatry 20090101

Marked hydronephrosis and hydroureter after distigmine therapy in an adult male patient with paraplegia due to spinal cord injury: a case report.

Cases journal 20090101

Oxybutynin extended release for the management of overactive bladder: a clinical review.

Drug design, development and therapy 20090101

Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence.

BMC urology 20090101

Ureteral stent discomfort: Etiology and management.

Indian journal of urology : IJU : journal of the Urological Society of India 20090101

Fesoterodine for the treatment of urinary incontinence and overactive bladder.

Therapeutics and clinical risk management 20090101

Behavioral intervention versus pharmacotherapy or their combinations in the management of overactive bladder dysfunction.

Advances in urology 20090101

Complications of Benchekroun vesicostomy in a spina bifida patient: severe stenosis requiring permanent suprapubic cystostomy, recurrent vesical calculi and abdominal hernia containing ileocystoplasty - a case report.

Cases journal 20090101

Plasmacytoid urothelial carcinoma of the bladder: a case report.

Cases journal 20090101

The symptomatic management of multiple sclerosis.

Annals of Indian Academy of Neurology 20090101

Rehabilitation challenges in multiple sclerosis.

Annals of Indian Academy of Neurology 20090101

Development of cardiomyopathy and atrial tachyarrhythmias associated with activating autoantibodies to beta-adrenergic and muscarinic receptors.

Journal of the American Society of Hypertension : JASH 20090101

Allosteric kinetics of human carboxylesterase 1: species differences and interindividual variability.

Journal of pharmaceutical sciences 20081201

The role of combination medical therapy in benign prostatic hyperplasia.

International journal of impotence research 20081201

Discontinuation rates of anticholinergic medications used for the treatment of lower urinary tract symptoms.

Obstetrics and gynecology 20081201

Treatment interventions in nursing home residents with urinary incontinence: a systematic review of randomized trials.

Mayo Clinic proceedings 20081201

Suppressive activity of tiotropium bromide on matrix metalloproteinase production from lung fibroblasts in vitro.

International journal of chronic obstructive pulmonary disease 20081201

Enantioselective analysis of oxybutynin and N-desethyloxybutynin with application to an in vitro biotransformation study.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20081101

Anticholinergic drugs, bladder retraining and their combination for urge urinary incontinence: a pilot randomised trial.

International urogynecology journal and pelvic floor dysfunction 20081101

Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacin.

International journal of clinical practice 20081101

Darifenacin treatment for overactive bladder in patients who expressed dissatisfaction with prior extended-release antimuscarinic therapy.

International journal of clinical practice 20081101

The effects of reformulation: improved therapeutic index.

Current urology reports 20081101

Efficacy and safety of solifenacin succinate in Korean patients with overactive bladder: a randomised, prospective, double-blind, multicentre study.

International journal of clinical practice 20081101

Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.

Journal of medicinal chemistry 20081009

A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder.

European urology 20081001

Sonographic evaluation of gallbladder contractility in patients with spinal cord injury.

Journal of clinical ultrasound : JCU 20081001

The relevance of urodynamic studies for Urge syndrome and dysfunctional voiding: a multicenter controlled trial in children.

The Journal of urology 20081001

New treatment protocol for primary nocturnal enuresis in children according to ultrasound bladder measurements.

Saudi medical journal 20081001

The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis.

European urology 20080901

Fixed drug eruption to oxybutynin.

Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20080901

Intravesical oxybutynin for children with poorly compliant neurogenic bladder: a systematic review.

The Journal of urology 20080901

Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: randomized, double-blind, placebo-controlled study.

Mayo Clinic proceedings 20080901

Choice of antimuscarinic agents for overactive bladder in the older patient: focus on darifenacin.

Clinical interventions in aging 20080901

Prospective randomized comparison of oxybutynin, functional electrostimulation, and pelvic floor training for treatment of detrusor overactivity in women.

International urogynecology journal and pelvic floor dysfunction 20080801

Formulation study of intravesical oxybutynin instillation solution with enhanced retention in bladder.

Chemical & pharmaceutical bulletin 20080801

Single-blind, randomized, controlled trial of pelvic floor muscle training, electrical stimulation, vaginal cones, and no active treatment in the management of stress urinary incontinence.

Clinics (Sao Paulo, Brazil) 20080801

Sustainability of remission of pediatric primary nocturnal enuresis--comparison of remission using Try for Dry vs. non-Try for Dry treatment plans.

Urologic nursing 20080801

Contraindicated medication use among patients in a memory disorders clinic.

The American journal of geriatric pharmacotherapy 20080801

Semiparametric mixed-effects analysis of PK/PD models using differential equations.

Journal of pharmacokinetics and pharmacodynamics 20080801

Anticholinergic activity of 107 medications commonly used by older adults.

Journal of the American Geriatrics Society 20080701

Therapeutic effects of the putative P2X3/P2X2/3 antagonist A-317491 on cyclophosphamide-induced cystitis in rats.

Naunyn-Schmiedeberg's archives of pharmacology 20080601

Signal transduction underlying the control of urinary bladder smooth muscle tone by muscarinic receptors and beta-adrenoceptors.

Naunyn-Schmiedeberg's archives of pharmacology 20080601

In vivo characterization of muscarinic receptors in peripheral tissues: evaluation of bladder selectivity of anticholinergic agents to treat overactive bladder.

Naunyn-Schmiedeberg's archives of pharmacology 20080601

In vivo quantitative autoradiographic analysis of brain muscarinic receptor occupancy by antimuscarinic agents for overactive bladder treatment.

The Journal of pharmacology and experimental therapeutics 20080601

Treatment of the neurogenic bladder in spina bifida.

Pediatric nephrology (Berlin, Germany) 20080601

Estimation of the impact of noncompliance on pharmacokinetics: an analysis of the influence of dosing regimens.

British journal of clinical pharmacology 20080601

Transient bilateral blindness and posterior reversible encephalopathy syndrome: a rare complication of enuresis treatment.

Journal of paediatrics and child health 20080601

Alteration of muscarinic and purinergic receptors in urinary bladder of rats with cyclophosphamide-induced interstitial cystitis.

Neuroscience letters 20080502

The neurogenic bladder: medical treatment.

Pediatric nephrology (Berlin, Germany) 20080501

Effective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side-effects.

European urology 20080501

A prospective, randomized, double-blinded placebo-controlled comparison of extended release oxybutynin versus phenazopyridine for the management of postoperative ureteral stent discomfort.

Urology 20080501

Dual use of bladder anticholinergics and cholinesterase inhibitors: long-term functional and cognitive outcomes.

Journal of the American Geriatrics Society 20080501

Randomized, placebo-controlled trial of the cognitive effect, safety, and tolerability of oral extended-release oxybutynin in cognitively impaired nursing home residents with urge urinary incontinence.

Journal of the American Geriatrics Society 20080501

Urgency in overactive bladder: translating experimental data into clinical practice.

Drugs of today (Barcelona, Spain : 1998) 20080501

Neurogenic bladder: etiology and assessment.

Pediatric nephrology (Berlin, Germany) 20080401

Pharmacological characterization of a novel investigational antimuscarinic drug, fesoterodine, in vitro and in vivo.

BJU international 20080401

A comparison of the efficacy of darifenacin alone vs. darifenacin plus a Behavioural Modification Programme upon the symptoms of overactive bladder.

International journal of clinical practice 20080401

Persistence, adherence, and switch rates among extended-release and immediate-release overactive bladder medications in a regional managed care plan.

Journal of managed care pharmacy : JMCP 20080401

Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women.

Annals of internal medicine 20080318

Does oxybutynin alter plaques, amyloid beta peptides and behavior in a mouse model of Alzheimer's disease?

The Journal of urology 20080301

A simple validated scale to measure urgency.

The Journal of urology 20080301

Oxybutynin effects on Staphylococcus epidermidis biofilm production.

Southern medical journal 20080301

Vesicoureteric reflux deterioration in monozygotic twins.

Indian journal of pediatrics 20080301

[High performance liquid chromatographic separation of oxybutynin enantiomers using chiral mobile phase additive].

Se pu = Chinese journal of chromatography 20080301

A review of solifenacin in the treatment of urinary incontinence.

Therapeutics and clinical risk management 20080201

Tolterodine does not affect memory assessed by passive-avoidance response test in mice.

European journal of pharmacology 20080128

Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.

Journal of medicinal chemistry 20080124

Rehabilitation versus drug therapy for urge urinary incontinence: long-term outcomes.

International urogynecology journal and pelvic floor dysfunction 20080101

Pharmacologic evaluation of pressor and visceromotor reflex responses to bladder distension.

Neurourology and urodynamics 20080101

The effects of anticholinergic drugs on attention span and short-term memory skills in children.

Neurourology and urodynamics 20080101

Pharmacokinetic-pharmacodynamic modeling of the effectiveness and safety of buprenorphine and fentanyl in rats.

Pharmaceutical research 20080101

Effects of oxybutynin transdermal system on health-related quality of life and safety in men with overactive bladder and prostate conditions.

International journal of clinical practice 20080101

Pharmacological analysis of the interaction of antimuscarinic drugs at M(2) and M(3) muscarinic receptors in vivo using the pithed rat assay.

Naunyn-Schmiedeberg's archives of pharmacology 20080101

Better management of patients with overactive bladder with antimuscarinics?

International journal of clinical practice 20080101

Evolution of transdermal oxybutynin in the treatment of overactive bladder.

International journal of clinical practice 20080101

Survey assessment of continuation of and satisfaction with pharmacological treatment for urinary incontinence.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20080101

Exercise-induced sweating in healthy subjects as a model to predict a drug's sweat-reducing properties in hyperhydrosis: a prospective, placebo-controlled, double-blind study.

Acta dermato-venereologica 20080101

A new method for producing urinary bladder hyperactivity using a non-invasive transient intravesical infusion of acetic acid in conscious rats.

Journal of pharmacological and toxicological methods 20080101

Pharmacological effects of solifenacin on human isolated urinary bladder.

Pharmacology 20080101

Effect of oxybutynin on exercise-induced sweating in healthy individuals.

The Journal of dermatological treatment 20080101

Hyperhidrosis: medical and surgical treatment.

Eplasty 20080101

Treatment outcome of day-time urinary incontinence in children.

Scandinavian journal of urology and nephrology 20080101

[Comparative characteristics of M-cholinolytics in combined treatment of mixed urinary incontinence in women].

Urologiia (Moscow, Russia : 1999) 20080101

Serum anticholinergic activity and cerebral cholinergic dysfunction: an EEG study in frail elderly with and without delirium.

BMC neuroscience 20080101

Bladder dysfunction and vesicoureteral reflux.

Advances in urology 20080101

Polymeric matrix membrane sensors for stability-indicating potentiometric determination of oxybutynin hydrochloride and flavoxate hydrochloride urogenital system drugs.

Journal of AOAC International 20080101

Clinical and urodynamic efficacy of oxybutynin and verapamil in the treatment of nocturnal enuresis after formation of orthotopic ileal neobladders. A prospective, randomized, crossover study.

Scandinavian journal of urology and nephrology 20080101

The MATRIX study: assessment of health-related quality of life in adults with the use of transdermal oxybutynin.

Director (Cincinnati, Ohio) 20080101

The MATRIX study: evaluating the data in older adults.

Director (Cincinnati, Ohio) 20080101

The MATRIX study: evaluating the data in older adults.

Director (Cincinnati, Ohio) 20080101

Practical management of nocturia in urology.

Indian journal of urology : IJU : journal of the Urological Society of India 20080101

Patient perspectives in the management of overactive bladder, focus on transdermal oxybutynin.

Patient preference and adherence 20080101

A novel metered dose transdermal spray formulation for oxybutynin.

Indian journal of pharmaceutical sciences 20080101

Botulinum-A toxin: solo treatment for neuropathic noncompliant bladder.

The Journal of urology 20071201

Oxybutynin-associated esotropia.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 20071201

Treatment with modified intravesical oxybutynin chloride for neurogenic bladder in children.

Journal of pediatric urology 20071201

Vardenafil improves urodynamic parameters in men with spinal cord injury: results from a single dose, pilot study.

The Journal of urology 20071101

Do holding exercises or antimuscarinics increase maximum voided volume in monosymptomatic nocturnal enuresis? A randomized controlled trial in children.

The Journal of urology 20071101

Muscarinic receptor antagonists for overactive bladder.

BJU international 20071101

The preparation and human muscarinic receptor profiling of oxybutynin and N-desethyloxybutynin enantiomers.

Medicinal chemistry (Shariqah (United Arab Emirates)) 20071101

Comparative in vivo uroselectivity profiles of anticholinergics, tested in a novel anesthetized rabbit model.

European journal of pharmacology 20071031

Adsorptive stripping voltammetric behavior and determination of anticholinergic agent oxybutynin chloride on a mercury electrode.

Journal of colloid and interface science 20071015

Sublingual oxybutynin reduces postoperative pain related to indwelling bladder catheter after radical retropubic prostatectomy.

British journal of anaesthesia 20071001

Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele.